Cite
HARVARD Citation
Fehlings, M. et al. (2019). Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. Journal for immunotherapy of cancer. 7 (1), p. . [Online].